2 dagar sedan · Gilead Sciences will present their latest quarterly figures on April 29. Analysts expect Gilead Sciences will release earnings per share of $2.08. Follow Gilead Sciences stock price in real-time

30 May 2019 AIDS activist, publicly challenged Daniel O'Day, CEO of Gilead Sciences (right) , to lower the price of Gilead's HIV prevention drug Truvada.

TradingView.com. Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages. Just enter your email address below. GILD Stock Summary. GILD has a higher Stock quote and company snapshot for GILEAD SCIENCES INC (GILD), including profile, stock chart, recent news and events, analyst opinions, and research Gilead Sciences Inc. is a US biopharmaceutical company founded in 1987.

2020-08-13 · View today's stock price, news and analysis for Gilead Sciences Inc. (GILD). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. 2021-02-01 · Gilead buys more Arcus Biosciences stock, at a price above the record close Published: Feb. 1, 2021 at 8:13 a.m. ET Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan Understanding stock price lookup is a basic yet essential requirement for any serious investor.

The Gilead Sciences 52-week high stock price is 85.67, which is 30.3% above the current share price. The Gilead Sciences 52-week low stock price is 56.56, which is 14% below the current share price. The average Gilead Sciences stock price for the last 52 weeks is 67.20.

Gilead Sciences Inc Share Price - GILD. Current Price. 66.79. 0.41. 0.62%. Intraday Gilead Sciences Chart. Intraday Gilead Sciences Chart. Bid Price, Offer Price.

2020-07-28 · GILD:NASDAQ GS Stock Quote - Gilead Sciences Inc - Bloomberg Markets. DJIA. 34,077.63.

Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages. Just enter your email address below. GILD Stock Summary. GILD has a higher

GILD's current price/earnings ratio is 682.34, which is higher than 98.66% of US stocks with positive earnings. 2 days ago Find real-time GILD - Gilead Sciences Inc stock quotes, company profile, news and forecasts from CNN Business. Gilead Sciences has a beta of 0.51, suggesting that its stock price is 49% less volatile than the S&P 500. Comparatively, Alexion Pharmaceuticals has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Institutional and Insider Ownership.

ET Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets. The Many investors turn to CNBC stock market live for daily updates on the companies they're watching. Read on for 15 things to know about the U.S. stock market. : Get the latest Gilead Sciences stock price and detailed information including news, historical charts and realtime prices.
Ahlens tempo

View which stocks have been most impacted by COVID-19. Rating. ImmuCell Corporation ( ICCC) $9.25.

S&P 500. 4,163.26.
Barn gråter när mamma sjunger

Gilead retains 20-year remdesivir patents in more than 70 countries. Gilead has also been accused of price-gouging on other medications developed with public funding, including AIDS PrEP drug Tenofovir and hepatitis C drug sofosbuvir as well as Remdesivir. Remdesivir for treatment of patients with COVID-19

Evolution of the average Target Price on GILEAD SCIENCES, INC. Stock quotes are provided by Factset, Morningstar and S&P Capital IQ 2020-04-17 2020-07-01 2020-03-16 2020-12-23 1 day ago 2020-06-05 2021-04-12 2021-02-01 2021-01-23 2020-04-09 1 day ago 2021-03-18 Gilead retains 20-year remdesivir patents in more than 70 countries. Gilead has also been accused of price-gouging on other medications developed with public funding, including AIDS PrEP drug Tenofovir and hepatitis C drug sofosbuvir as well as Remdesivir. Remdesivir for … Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing. Get the latest Gilead Sciences, Inc. (GILD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. GILD | Complete Gilead Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. 2020-07-28 · GILD:NASDAQ GS Stock Quote - Gilead Sciences Inc - Bloomberg Markets.